Nov 18, 2025 • Stock Titan
NEUTRAL
[Form 4] GCM Grosvenor Inc. Insider Trading Activity
This article details an insider trading activity at GCM Grosvenor Inc. (GCMG), reporting a grant of 13,409 restricted stock units (RSUs) to Principal Accounting Officer, Kathleen Patricia Sullivan, on November 15, 2025. The RSUs will vest on March 1, 2026, and can be settled in Class A common stock, cash, or a mix. The report includes the full SEC Form 4 filing and an FAQ section explaining the details of the RSU grant.
Nov 18, 2025 • Stock Titan
NEUTRAL
[Form 4] GCM Grosvenor Inc. Insider Trading Activity
GCM Grosvenor Inc. (GCMG) reported new equity awards for its Chief Financial Officer, Pamela L. Bentley, as detailed in a Form 4 filing. The CFO received two grants of Restricted Stock Units (RSUs) on November 15, 2025, totaling 39,845 and 600,000 RSUs respectively, with various vesting schedules extending up to May 2032. These RSUs are contingent on continued service and represent the right to receive Class A Common Stock.
Nov 18, 2025 • Stock Titan
NEUTRAL
[Form 4] GCM Grosvenor Inc. Insider Trading Activity
A GCM Grosvenor Inc. insider, Michael Jay Sacks, who is a Director, 10% owner, and CEO, exercised 900,000 warrants on a cashless basis to purchase Class A common stock at $11.50 per share on November 14, 2025. This transaction resulted in 6,988 shares of Class A common stock being issued and 893,012 warrant shares being withheld to cover the exercise price. Following the transaction, the insider indirectly beneficially owns 6,988 Class A shares.
Nov 17, 2025 • Stock Titan
NEUTRAL
[8-K] GCM Grosvenor Inc. Reports Material Event | GCMG SEC Filing - Form 8-K
GCM Grosvenor Inc. (GCMG) entered into an Equity Distribution Agreement with Morgan Stanley & Co. LLC to sell up to $100 million of its Class A common stock through an at-the-market offering program. The company will pay a 2.5% commission on gross sales proceeds and intends to use the net proceeds for general working capital and corporate purposes, including financing investments. This filing was made on November 17, 2025, under an effective shelf registration statement.